Terry Grimm, founder, president and senior scientist of Niowave. Grimm founded Niowave in 2006, and it has grown to be a world industrial leader in superconducting accelerator research. In 2008, the firm qualified as the second U.S. vendor for accelerating cavities for the International Linear Collider. In 2009, Niowave became the first private company in the world to design, fabricate, and test a superconducting electron injector. Niowave has grown to 50 employees, and has received numerous awards, including being named among Michigan's 50 Companies to Watch in 2008. Prior to Niowave, Grimm was a senior physicist and adjunct professor at the Michigan State University National Superconducting Cyclotron Laboratory.

Speaker Michael Beard, Executive Director, Advocacy, United Nations FoundationWe're excited to present a variety of speakers from Michigan State University, the State of Michigan, and private industry to speak about cutting-edge research and initiatives making sustainable light energy more achievable and affordable for today and for future generations. Speakers include: MSU Dept. of Chemical Engineering (Richard Lunt), MSU Dept. of Chemistry (James McCusker, Warren Beck, Thomas Hamann, Remi Beaulac), MSU Dept. of Physics & Astronomy (Chong-Yu Ruan), MSU Technologies (Richard Chylla), Michigan Public Service Commission (Julie Baldwin). In addition, please join us for our UN Day Anniversary Gala with keynote by Harvard Professor and UN Science & Technology Award winner Daniel Nocera on Sunday, Oct. 25. Registration at www.GLUNA.orgThe Global Business Club of Mid-Michigan focuses on global issues of interest to the mid-Michigan business community. The monthly GB Club luncheons provide outstanding speakers and relaxed networking opportunities. With extensive international experience, the speakers wrap personal insights around a practical and up-to-the-minute approach to conducting international trade.

Dr. Raghunath Subramaniyam will talk about what it takes to lead and manage multinational firms in India? Within a few decades, India will be the worlds most populous nation and one of its largest economies. But it is also a complex and challenging market. Many global companies are therefore cautious when it comes to investing in India. But India is not a market that can be ignored. A $2 trillion economy growing at 5-6%, it is an important market. Even more importantly, India is an archetype for most emerging markets, many of which present similar challenges but not the same potential. The discussion will include findings of a detailed longitudinal study of a large MNC in healthcare focusing on their India and emerging markets operations. This study will be used to illustrate how a large MNC has retained strategic flexibility in its own specific ways of adapting to the emerging markets in Asia such as India. We will discuss the emerging business environment in
India specifically with the changes in the government and its policies with specific focus on healthcare.